Cytogenetic studies on recipients of allogeneic bone marrow using the sex chromosomes as marker of cellular origin
Lawler S, Baker MC, Harris H, Morgenstern G. Cytogenetic studies on recipients of allogeneic bone marrow using the sex chromosomes as marker of cellular origin. Br J Haematol 1985; 56: 431-443.
Cytogenetic studies on recipients of allogeneic bone marrow transplants after fractionated total body irradiation
Schmitz CRJ, Godde-Salz E, Loffler H. Cytogenetic studies on recipients of allogeneic bone marrow transplants after fractionated total body irradiation. Br J Haematol 1985; 60: 239-244.
The significance of host hemopoietic cells detected by cytogenetic analysis of bone marrow transplants
Walker H, Singer CRJ, Patterson J et al. The significance of host hemopoietic cells detected by cytogenetic analysis of bone marrow transplants. Br J Haematol 1986; 62: 385-391.
Chromosome studies in patients with acute non-lymphocytic leukemia submitted to bone marrow transplantation. Results of a European Cooperative Study
Zaccaria A, Rosti G, Testoni N et al. Chromosome studies in patients with acute non-lymphocytic leukemia submitted to bone marrow transplantation. Results of a European Cooperative Study. Cancer Genet Cytogenet 1987; 26: 51-58.
Cytogenetic events after bone marrow transplantation for Philadelphia chromosome positive chronic myeloid leukemia
Zaccaria A, Rosti G, Testoni N et al. Cytogenetic events after bone marrow transplantation for Philadelphia chromosome positive chronic myeloid leukemia. Leukemia Res 1991; 15: 289-296.
Chromosome abnormalities after autologous bone marrow transplantation with marrow treated by cyclophosphamide derivatives
Van den Akker J, Gorin NC, Laporte JP et al. Chromosome abnormalities after autologous bone marrow transplantation with marrow treated by cyclophosphamide derivatives. Lancet 1985; i: 1211-1212.
Multiple chromosome abnormalities in patients with acute leukemia after autologous bone marrow transplantation using total body irradiation and marrow purged with mafosfamide
Perot C, van den Akker J, Laporte JP et al. Multiple chromosome abnormalities in patients with acute leukemia after autologous bone marrow transplantation using total body irradiation and marrow purged with mafosfamide. Leukemia 1993; 7: 509-515.
Autologous bone marrow transplantation in late first complete remission improves outcome in acute myelogenous leukemia: A single centre experience
Miggiano MC, Gherlinzoni F, Rosti G et al. Autologous bone marrow transplantation in late first complete remission improves outcome in acute myelogenous leukemia: a single centre experience. Leukemia 1996; 10: 402-409.
Autologous bone marrow transplantation in patients with acute nonlymphocytic leukemia, using ex vivo marrow treatment with 4-hydroxperoxycyclophosphamide
Yeager AM, Kaizer H, Santos GW et al. Autologous bone marrow transplantation in patients with acute nonlymphocytic leukemia, using ex vivo marrow treatment with 4-hydroxperoxycyclophosphamide. New Engl J Med 1986; 315: 141-147.
Myelodysplastic syndrome after autologous bone marrow transplantation: An additional late complication of curative cancer therapy
Miller JM, Arthur DC, Litz CE et al. Myelodysplastic syndrome after autologous bone marrow transplantation: an additional late complication of curative cancer therapy. Blood 1994; 83: 3780-3786.
Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: Further evidence for characteristic abnormalities of chromosomes nos 5 and 7
Le Beau MM, Albain KS, Larson RA. Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes nos 5 and 7. J Clin Oncol 1986; 4: 325-329.